WEBVIEW IRT Trademark

Trademark Overview

On Wednesday, November 14, 2018, a trademark application was filed for WEBVIEW IRT with the United States Patent and Trademark Office. The USPTO has given the WEBVIEW IRT trademark a serial number of 88193412. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, July 1, 2020. This trademark is owned by Amarex Clinical Research LLC. The WEBVIEW IRT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services
webview irt

General Information

Serial Number88193412
Word MarkWEBVIEW IRT
Filing DateWednesday, November 14, 2018
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, July 1, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"IRT"
Goods and ServicesPharmaceutical drug development services
Pseudo MarkWEB VIEW INTERACTIVE RESPONSE TECHNOLOGY

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 16, 2019
Primary Code042
First Use Anywhere DateMonday, May 20, 2002
First Use In Commerce DateMonday, May 20, 2002

Trademark Owner History

Party NameAmarex Clinical Research LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGermantown, MD 20874

Trademark Events

Event DateEvent Description
Wednesday, July 1, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, July 1, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, December 17, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 17, 2019FINAL REFUSAL E-MAILED
Tuesday, December 17, 2019FINAL REFUSAL WRITTEN
Friday, December 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2019ASSIGNED TO LIE
Tuesday, December 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 20, 2019NON-FINAL ACTION E-MAILED
Tuesday, August 20, 2019NON-FINAL ACTION WRITTEN
Friday, August 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 15, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 19, 2019NON-FINAL ACTION E-MAILED
Tuesday, February 19, 2019NON-FINAL ACTION WRITTEN
Tuesday, February 19, 2019ASSIGNED TO EXAMINER
Saturday, December 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 17, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

webview services development drug pharmaceutical